Meeting
2023 ASCO Quality Care Symposium
End-of-life chemotherapy and palliative care utilization among patients with breast cancer treated at a safety-net system.
Authors
Lauren Bell
UT Southwestern Medical Center, Dallas, TX
Lauren Bell, Hsiao Ching Li, Samira K. Syed, Glenda Maria Delgado Ramos, Nisha Unni, Navid Sadeghi
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Poster Session B
Track
Health Care Access, Equity, and Disparities,Technology and Innovation in Quality of Care,Palliative and Supportive Care
Sub Track
End-of-Life Care
Citation
JCO Oncol Pract 19, 2023 (suppl 11; abstr 241)
DOI
10.1200/OP.2023.19.11_suppl.241
Abstract #
241
Poster Bd #
H4
Abstract Disclosures
Similar Posters
Poster
2015 Breast Cancer Symposium
Cancer team approach for prescreening and identifying breast cancer survivors as part of survivorship care plan implementation.
First Author: Oana Cristina Danciu
Poster
2024 ASCO Breakthrough
OPERA-01: A randomized, open-label, phase 3 study of palazestrant (OP-1250) vs standard-of-care for patients with ER+, HER2- advanced or metastatic breast cancer after endocrine therapy and CDK4/6 inhibitors.
First Author: Joohyuk Sohn
Poster
2023 ASCO Quality Care Symposium
Provider- and facility-level factors in relation to patients’ receipt of chemotherapy, time to chemotherapy initiation, and receipt of guideline regimens: Results from the optimal breast cancer chemotherapy dosing study.
First Author: Elizabeth Kantor
Poster
2023 ASCO Quality Care Symposium
Acceptability to patients and caregivers of a prognostic tool for near-term death from advanced breast cancer.
First Author: Emily Miller Ray